MedTrace Logo

BLOOD BIOMARKERS in PAEDIATRIC MTBI

NCT06233851 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2024-11-07

No results posted yet for this study

Summary

The goal of this observational study is to identify blood biomarkers that could help in the management of paediatric patients with mild TBI. The main questions it aims to answer are:

1. How can blood biomarkers reduce unnecessary CT scan and reduce the length of stay at the emergency department?
2. How can blood biomarker predict post-concussion symptoms?

Participants will have a blood sample taken when they are admitted at emergency department and will receive a questionnaire describing their symptoms 14 days and 3 months after their trauma.

Conditions

  • Mild Traumatic Brain Injury

Sponsors & Collaborators

  • Pediatric Clinical Research Platform

    lead OTHER

Principal Investigators

  • Sergio Manzano, MD · University Hospital, Geneva

Eligibility

Min Age
0 Months
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-06
Primary Completion
2024-06-10
Completion
2024-07-08

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06233851 on ClinicalTrials.gov